Search results

• 25I-NBOMe
  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp.jpg "Council
  28 KB (4,417 words) - 14:00, 16 April 2024
• 25N-NBOMe
  and subsequently investigated by a team at Purdue University led by David E. Nichols. 25N-NBOMe has a notably shorter duration than the rest of the 25x-NBOMe
  18 KB (3,141 words) - 20:58, 19 July 2022
• 25C-NBOMe
  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp.jpg https://www
  26 KB (4,063 words) - 23:35, 21 April 2024
• 6-APB
  MDA, MDMA, 5-APB, and 5-MAPB. 6-APB was first synthesized in 1993 by David E. Nichols as a potential non-neurotoxic alternative to MDMA. However, recreational
  33 KB (4,870 words) - 14:34, 16 April 2024
• Research chemicals
  vendors as both 2C-B-FLY and 2C-E. The former is active in the 200-800μg range and is significantly more potent than 2C-E. These situations can be avoided
  19 KB (2,209 words) - 23:08, 21 April 2024
• DMT
  8297217. Nichols, David E. (2016). Barker, Eric L., ed. "Psychedelics". Pharmacological Reviews. 68 (2): 264–355. doi:10.1124/pr.115.011478. eISSN 1521-0081
  58 KB (7,681 words) - 22:15, 14 May 2024
• Entactogen
  Ralph Metzner and David E. Nichols as a term to denote a therapeutic class of drugs that includes MDMA and phenethylamine relatives. Nichols later rejected
  6 KB (767 words) - 05:26, 22 September 2023
• 2C-T
  was first synthesized as part of a collaboration between researchers David E. Nichols and Alexander Shulgin. Its effects and synthesis is described in Shulgin's
  13 KB (1,528 words) - 23:08, 29 May 2021
• LSD
  ISSN 1461-1457.  Nichols, David E. (2016). Barker, Eric L., ed. "Psychedelics". Pharmacological Reviews. 68 (2): 264–355. doi:10.1124/pr.115.011478. eISSN 1521-0081
  100 KB (12,100 words) - 08:20, 3 January 2024
• AL-LAD
  R., & Nichols, D. E. (1994). Lysergamides Revisited. NIDA Research Monograph, 146, 52-73. PMID: 8742794. Hoffman, Andrew J.; Nichols, David E. (1985)
  30 KB (4,063 words) - 04:16, 30 June 2022
• 4-AcO-DMT
  is unknown when it was first explored in humans. A paper authored by David E. Nichols in 1999 proposed its potential use as an alternative to psilocybin
  30 KB (4,417 words) - 23:36, 21 April 2024
• PRO-LAD
  and ETH-LAD. PRO-LAD was first investigated by Andrew J. Hoffman and David E. Nichols in 1984 as part of a series of LSD analogs. It was later described
  21 KB (2,993 words) - 16:35, 29 May 2021
• MDAI
  was developed by the American medicinal chemist and pharmacologist David E. Nichols during the 1990s at Purdue University.[citation needed] in the 2010s
  17 KB (2,560 words) - 07:40, 12 October 2023
• Escaline
  Benington, et al., in 1954, but was later re-examined in the laboratory of David E. Nichols who prepared a series of mescaline analogues, including proscaline
  12 KB (1,512 words) - 00:01, 21 December 2023
• 25I-NBOH
  synthesized and documented in 2006 by a team at Purdue University led by David Nichols.[citation needed] It has been studied in its 11C radiolabelled form as
  19 KB (2,665 words) - 20:05, 19 July 2022
• LSZ
  3 (11). doi:10.1371/journal.pmed.0030437. eISSN 1549-1676. ISSN 1549-1277. PMID 17105338.  Nichols, David E. (2016). Barker, Eric L., ed. "Psychedelics"
  14 KB (1,746 words) - 04:58, 2 December 2022
• Mescaline
  Design) Nichols, David E. (2016). Barker, Eric L., ed. "Psychedelics". Pharmacological Reviews. 68 (2): 264–355. doi:10.1124/pr.115.011478 . eISSN 1521-0081
  35 KB (3,957 words) - 06:11, 30 June 2022
• MiPLA
  has recently been researched in greater detail by by a team led by David E. Nichols at Purdue University.[citation needed] MiPLA and its effects are also
  21 KB (2,783 words) - 04:48, 30 June 2022
• Proscaline
  and allylescaline. The synthesis of proscaline was first published by David E. Nichols in 1977. Around the same time, Alexander Shulgin sampled and evaluated
  10 KB (1,076 words) - 21:01, 29 May 2021
• 5-APB
  was first synthesized in 1993 by psychedelic chemist and researcher David E. Nichols as a potential non-neurotoxic alternative to MDMA. However, it did
  14 KB (2,336 words) - 23:43, 21 April 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)